Besides, the survival curve analysis also shows that CDCA1–6 and CDCA8 with low-methylation levels significantly deteriorate the overall survival of patients in HCC (Figure 10), further suggesting that methylation levels of CDCAs can be regarded as the predictive biomarkers for determining prognosis and immune infiltration in HCC. The gene discussed is NUF2; the disease is hepatocellular carcinoma.